Cargando…
Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside
The RNA interference (RNAi) pathway possesses immense potential in silencing any gene in human cells. Small interfering RNA (siRNA) can efficiently trigger RNAi silencing of specific genes. FDA Approval of siRNA therapeutics in recent years garnered a new hope in siRNA therapeutics. However, their t...
Autores principales: | Sajid, Muhammad Imran, Moazzam, Muhammad, Kato, Shun, Yeseom Cho, Kayley, Tiwari, Rakesh Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600125/ https://www.ncbi.nlm.nih.gov/pubmed/33036435 http://dx.doi.org/10.3390/ph13100294 |
Ejemplares similares
-
Lipid nanoparticles for targeted siRNA delivery – going from bench to bedside
por: Zatsepin, Timofei S, et al.
Publicado: (2016) -
Cyclic Peptide-Gadolinium Nanocomplexes as siRNA Delivery Tools
por: Nasrolahi Shirazi, Amir, et al.
Publicado: (2021) -
Oleyl Conjugated Histidine-Arginine Cell-Penetrating Peptides as Promising Agents for siRNA Delivery
por: Sajid, Muhammad Imran, et al.
Publicado: (2022) -
From bench to bedside: Improving the clinical safety of GalNAc–siRNA conjugates using seed-pairing destabilization
por: Schlegel, Mark K, et al.
Publicado: (2022) -
Digital therapeutics from bench to bedside
por: Wang, Changwon, et al.
Publicado: (2023)